IL261446B
Partially deuterated substituted heterocycle fused gamma-carbolines and pharmaceutical compositions comprising them
Abstract
This record has no abstract on file.
Term
No projected expiry on record.
- Priority and filed
- Published
- Today
64 members in 18 offices
Members64
| Document | Office | Kind | |
|---|---|---|---|
| CA3016353A1 | Canada | A1 | |
| WO2017165843A1 | World Intellectual Property Organization (WIPO) | A1 | |
| AU2017238842A1 | Australia | A1 | |
| IL261446A | Israel | A | |
| CN108778277A | China | A | |
| KR20180128453A | Republic of Korea | A | |
| EP3407889A1 | European Patent Office (EPO) | A1 | |
| MX2018011676A | Mexico | A | |
| BR112018069594A2 | Brazil | A2 | |
| EP3407889A4 | European Patent Office (EPO) | A4 | |
| JP2019512525A | Japan | A | |
| AU2017238842B2 | Australia | B2 | |
| US2019231780A1 | United States of America | A1 | |
| JP6686168B2 | Japan | B2 | |
| RU2018137496A | Russian Federation | A | |
| RU2018137496A3 | Russian Federation | A3 | |
| US10688097B2 | United States of America | B2 | |
| JP2020114856A | Japan | A | |
| RU2733975C2 | Russian Federation | C2 | |
| US2020352949A1 | United States of America | A1 | |
| IL261446BThis record | Israel | B | |
| JP6860724B2 | Japan | B2 | |
| CA3016353C | Canada | C | |
| IL281050A | Israel | A | |
| EP3407889B1 | European Patent Office (EPO) | B1 | |
| JP2021100970A | Japan | A | |
| PT3407889T | Portugal | T | |
| DK3407889T3 | Denmark | T3 | |
| US11096944B2 | United States of America | B2 | |
| SI3407889T1 | Slovenia | T1 | |
| EP3888656A1 | European Patent Office (EPO) | A1 | |
| PL3407889T3 | Poland | T3 | |
| ES2879888T3 | Spain | T3 | |
| HUE055334T2 | Hungary | T2 | |
| CN113754661A | China | A | |
| MX2021013564A | Mexico | A | |
| US2022008423A1 | United States of America | A1 | |
| IL281050B | Israel | B | |
| IL297676A | Israel | A | |
| JP7195362B2 | Japan | B2 | |
| KR102483124B1 | Republic of Korea | B1 | |
| KR20230003461A | Republic of Korea | A | |
| JP2023030006A | Japan | A | |
| IL281050B2 | Israel | B2 | |
| IL297676B1 | Israel | B1 | |
| US11723909B2 | United States of America | B2 | |
| IL304192A | Israel | A | |
| US2023346787A1 | United States of America | A1 | |
| IL297676B2 | Israel | B2 | |
| BR112018069594B1 | Brazil | B1 | |
| JP7404491B2 | Japan | B2 | |
| JP2024037860A | Japan | A | |
| KR102684468B1 | Republic of Korea | B1 | |
| IL304192B1 | Israel | B1 | |
| IL314312A | Israel | A | |
| IL304192B2 | Israel | B2 | |
| US12194044B2 | United States of America | B2 | |
| MX387700B | Mexico | B | |
| US2025099471A1 | United States of America | A1 | |
| IL314312B1 | Israel | B1 | |
| IL325375A | Israel | A | |
| JP7860948B2 | Japan | B2 | |
| IL314312B2 | Israel | B2 | |
| EP3888656B1 | European Patent Office (EPO) | B1 |
2 legal events, as the office reported them to INPADOC
Over the term
Point at a mark for the eventEvents
| Event | Code | |
|---|---|---|
| Patent renewedKB | KB | |
| Patent grantedGrantedFF | FF |
Numbers
- Publication
- 261446
- Application
- 26144618
Titles2
- English
- Partially deuterated substituted heterocycle fused gamma-carbolines and pharmaceutical compositions comprising them
- Hebrew
- הטרוציקלים מאוחים לגמא–קרבולינים שעברו דאוטרציה חלקית ומותמרים ותכשירי רוקחות המכילים אותם
Classification
- CPC, 19
- C07D471/16
- A61K31/4985
- C07D471/14
- A61K31/519
- A61K45/06
- A61P25/18
- A61P25/22
- A61P25/24
- A61P25/20
- A61P25/06
- A61P25/28
- A61P3/04
- A61P1/00
- A61P25/14
- A61P25/16
- A61P25/00
- A61K9/0004
- A61K2300/00
- A61K31/5383